5th Workshop on Virus Dynamics

virus workshop banner

Thank you for participating in the 5th Workshop on Virus Dynamics

This is an initiative that brought together virologists and immunologists with mathematical modelers and systems biologists to discuss current approaches and challenges in modeling and analyzing different aspects of virus dynamics.

This 5th version of the workshop was built on the success of previous ones in Frankfurt (2013), Toronto (2015), Heidelberg (2017) and Paris (2019).

Date:
Monday-Wednesday, October 04-06, 2021
Location:
Virtual
Cost:

$25

Contact Information:

Workshop Proceedings

Recordings of speaker presentations and poster slides are available to those who registered for the workshop. If you were registered and you did not receive an email with a link to these materials please contact workshop staff at wvd5@fredhutch.org

Featured Topics

The list of topics included:

  • HIV
  • HCV/HBV
  • SARS-CoV-2
  • Other viruses
  • Viral replication and natural history
  • Adaptive and innate immune responses
  • In vitro virus infection
  • Intracellular mechanisms
  • Treatment and cure
  • Vaccines
  • Prevention
  • Evolution
  • Computational and statistical tools

We actively encourage participation of researchers from around the globe, including junior scientists and members of underrepresented groups. 

Funding for this conference was made possible [in part] by 1 R13 AI 164789 - 01 from the National Institute of Allergy and Infectious Diseases. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Meeting Partner Societies and Institutions

Society for Mathematical Biology logo
Washington State University logo

Symposium Chairs

Josh Schiffer, M.D., M.Sc.

Josh Schiffer, M.D., M.Sc.

Associate Professor, Fred Hutchinson Cancer Research Center & University of Washington, Seattle, WA, USA

Dr. Schiffer is an infectious disease physician and researcher who develops mathematical models to address significant medical challenges. A major focus of his work is to analyze strategies to achieve an HIV cure in people who require antiviral drugs for their entire lifetime, due to reservoirs of latent virus. These models assess the potential of a wide variety of potential curative technologies. Dr. Schiffer and colleagues also use mathematical modeling to study how T cells help control numerous herpes viruses that cause disease in healthy people and in cancer patients with compromised immune systems. They develop models to explain when and how latent viruses reactivate and use models to optimize the effectiveness of antiviral drugs. His team is also focusing on COVID-19, including developing models of the immune response against the coronavirus and the best treatment strategies.

Elissa Schwartz, Ph.D.

Elissa Schwartz, Ph.D.

Associate Professor, Washington State University, Pullman, WA, USA

Dr. Schwartz’s research combines experimental and theoretical techniques to investigate mechanisms in virology, immunology, and infectious disease epidemiology. She uses mathematical and computational modeling of viral dynamics in conjunction with clinical and experimental data in order to predict biological mechanisms, determine biologically relevant rate parameters, and evaluate pathogenic mechanisms that are difficult to test directly. Her research group’s interdisciplinary approach aims to advance our basic understanding of disease mechanisms and to lead to new therapeutic strategies. Currently she is examining the determinants of virus control and escape in lentiviral infection, including human immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV). Other ongoing projects investigate viral evolution in bacteriophage populations, behavioral interventions in COVID-19 dynamics, and the effect of antiretroviral therapy on decreasing the development of renal disease among HIV+ populations.

Last Modified, October 23, 2021